Axena Health and Mayo Clinic Partner to Advance Urinary Incontinence Care
Axena Health and Mayo Clinic have partnered to integrate Mayo Clinic’s overactive bladder (OAB) educational content into Axena Health’s...
Daring Denali Therapeutics MPS II Study Delivers!
Denali Therapeutics announced primary analysis results from a Phase 1/2 study of tividenofusp alfa (DNL310) in 47 participants with...
CytoDyn Shows Statistically Significant Fibrosis Reversal
CytoDyn Inc. announced positive preclinical results for leronlimab, demonstrating a statistically significant reversal of liver fibrosis in three separate...
Wave Life Sciences Initiates Phase 1 Inlight Trial of WVE-007 in Obesity
Wave Life Sciences has initiated a Phase 1 clinical trial, INLIGHT, for WVE-007, a novel RNA interference (RNAi) therapy...
Tonix CD40L MAb Shows Promise in Kidney Transplant Rejection
Tonix Pharmaceuticals announced positive topline results from its Phase 1 single ascending dose trial of TNX-1500, an anti-CD40L monoclonal...
Trinity Biotech CGM Trial Shows Landmark First-Day Accuracy Gains
Trinity Biotech announced positive findings from a pre-pivotal trial of its next-generation continuous glucose monitoring (CGM) system, demonstrating significant...
Northwestern Medicine First in Aclarion’s Clarity Trial
Aclarion, Inc. launched its pivotal CLARITY trial at Northwestern Medicine, a leading clinical trial research center. The CLARITY trial...
FDA Approves Lipella’s LP-310 for Oral Lichen Planus
Lipella Pharmaceuticals (Nasdaq: LIPO) has received FDA approval for an Expanded Access Program (EAP) for LP-310, an oral rinse...
Vaxxas Appoints Global Vaccine Experts for Needle-Free Trials
Vaxxas, a clinical-stage biotech company, has appointed three prominent vaccine experts as advisors to guide product development and strategy....
AgelessRx Launches Oral GLP-1 Drops for Metabolic Health
AgelessRx has launched oral sublingual drops for the GLP-1 receptor agonists Semaglutide and Tirzepatide, offering a non-injectable alternative for...